News by Tag: Renal Cancer
Argos Therapeutics' gets FDA nod for its renal cancer drug
August 1, 2012
The approval of the Argos Therapeutics' renewed Special Protocol Assessment (SPA) with respect to the phase III clinical trial study by the FDA regulatory body has paved the way for use of the drug AGS-003 in establishing successful clinical results
August 1, 2012
The approval of the Argos Therapeutics' renewed Special Protocol Assessment (SPA) with respect to the phase III clinical trial study by the FDA regulatory body has paved the way for use of the drug AGS-003 in establishing successful clinical results